North Brunswick, NJ, United States of America

Hsiu Ying Sherry Wang

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.2

ph-index = 1


Company Filing History:


Years Active: 2015-2020

Loading Chart...
4 patents (USPTO):

Title: Innovator Spotlight: Hsiu Ying Sherry Wang and Her Transformative Contributions to Biomedical Engineering

Introduction: Hsiu Ying Sherry Wang is a prominent inventor based in North Brunswick, NJ, whose work is advancing the fields of cell therapy and tissue engineering. With a total of four patents to her name, she has made significant strides in developing innovative biomedical solutions.

Latest Patents: Among her latest inventions are two groundbreaking patents focusing on collagen matrices. The first patent, titled "Collagen Matrix for Cell Therapy," describes the use of an active collagen matrix for culturing mammalian cells, which can be utilized in the treatment of various diseases. The second patent, "Collagen Matrix for Tissue Engineering," similarly showcases the potential of this active matrix in supporting cell cultures and providing therapeutic applications.

Career Highlights: Hsiu Ying Sherry Wang is notably affiliated with Warsaw Orthopedic, Inc., where she applies her expertise to enhance orthopedic solutions. Her innovative work not only addresses challenges in biomedicine but also improves patient outcomes through advanced cell-based therapies.

Collaborations: She works alongside esteemed colleagues Lawrence A. Shimp and Abdulhafez A. Selem, contributing to a collaborative environment that fosters innovative research and development in biomedical engineering.

Conclusion: Hsiu Ying Sherry Wang's contributions to the field of biomedical engineering exemplify her commitment to innovation and excellence. Her patents, particularly in collagen matrices for cell therapy and tissue engineering, represent a significant leap forward in how we approach treatment methodologies for various ailments. Through collaboration and her dedication to research, Wang continues to lead the way in advancing our understanding of cellular therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…